Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:VRML

Vermillion (VRML) Stock Price, News & Analysis

Vermillion logo

About Vermillion Stock (NASDAQ:VRML)

Advanced Chart

Key Stats

Today's Range
$0.14
$0.16
50-Day Range
$2.54
$4.24
52-Week Range
$0.35
$5.78
Volume
29,408 shs
Average Volume
440,144 shs
Market Capitalization
$15.09 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive VRML Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vermillion and its competitors with MarketBeat's FREE daily newsletter.

VRML Stock News Headlines

Camellia Vermillion
Dr. Richard L. Knutson
Market Panic: Trump Just Dropped a Bomb on Your Stocks
tock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tariffs just lit the fuse. Millions of investors are blindsided as stocks plunge… but this is only Phase 1. If you're still holding the wrong assets, you could lose 30% or more in the coming weeks.
Vermillion Elementary School
Dr. Kenneth J. Vermillion
Vermillion High School
Sanford Vermillion Medical Center
See More Headlines

VRML Stock Analysis - Frequently Asked Questions

Vermillion, Inc. (NASDAQ:VRML) released its quarterly earnings data on Thursday, August, 8th. The company reported ($0.06) earnings per share (EPS) for the quarter. The business earned $1.14 million during the quarter. Vermillion had a negative trailing twelve-month return on equity of 155.25% and a negative net margin of 307.31%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Vermillion investors own include CombiMatrix (CBMX), Accelerate Diagnostics (AXDX), Himax Technologies (HIMX), Charter Communications (CHTR), Idera Pharmaceuticals (IDRA), Magnachip Semiconductor (MX) and Cardiff Oncology (TROV).

Company Calendar

Last Earnings
8/08/2019
Today
7/03/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Diagnostic Substances
Sub-Industry
N/A
Current Symbol
NASDAQ:VRML
Fax
N/A
Employees
43
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$15.24 million
Net Margins
-307.31%
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$4.54 million
Price / Cash Flow
N/A
Book Value
$0.09 per share
Price / Book
1.72

Miscellaneous

Free Float
N/A
Market Cap
$15.09 million
Optionable
Not Optionable
Beta
3.47
10 "Recession Proof" Stocks That Will Thrive in Any Market Cover

Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

This page (NASDAQ:VRML) was last updated on 7/3/2025 by MarketBeat.com Staff
From Our Partners